K Number
K042242
Date Cleared
2004-09-15

(27 days)

Product Code
Regulation Number
886.5925
Reference & Predicate Devices
N/A
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Alden HP 55 (methafilcon A) and Alden HP 59G (hioxifilcon A) Sphere and Toric Soft Contact Lenses For Daily Wear, are indicated for the correction of visual acuity in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia, and/or possess refractive astigmatism not exceeding 10 Diopters. They are available for either conventional wear or planned replacement modalities.

Device Description

Alden HP 55 (methafilcon A) and Alden HP59G (hioxifilcon A) Sphere & Toric Soft Contact Lenses

AI/ML Overview

The provided document is a 510(k) premarket notification letter for soft contact lenses. It does not contain information about the acceptance criteria or a study proving that a device (in the context of AI/software as a medical device) meets acceptance criteria.

The document discusses the substantial equivalence of Alden HP 55 (methafilcon A) and Alden HP59G (hioxifilcon A) Sphere & Toric Soft Contact Lenses to legally marketed predicate devices. The focus is on the regulatory pathway for these contact lenses, which fall under 21 CFR 886.5925, Soft (hydrophilic) contact lens, and are classified as Class II.

Therefore, I cannot extract the requested information about acceptance criteria and a study from this document, as it pertains to contact lenses and not a device that would typically have the kind of performance study details requested (e.g., sample sizes for test/training sets, ground truth establishment by experts, MRMC studies, standalone performance).

The information provided in the prompt is specific to a type of medical device (like an AI algorithm) that would undergo performance evaluation against explicit acceptance criteria, often involving clinical studies with human readers, ground truth, and statistical analysis. This document simply confirms the FDA's decision regarding the substantial equivalence of ophthalmic contact lenses based on their regulatory classification.

{0}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles a stylized human figure or a bird in flight, composed of flowing lines.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 1 5 2004

Alden Optical Laboratories, Inc. c/o Charles H. Creighton, President 13295 Broadway Alden, NY 14004

Re: K042242

Trade/Device Name: Alden HP 55 (methafilcon A) and Alden HP59G (hioxifilcon A) Sphere & Toric Soft Contact Lenses Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) contact lens Regulatory Class: Class II

Product Code: LPL Dated: August 17, 2004 Received: August 19, 2004

Dear Mr. Creighton:

We have reviewed your Section 510(k) premarket notification of intent to market the device wt nave reviewed your becarely be device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for use stated in the encroours) to regardy and the Medical Device Amendments, or to connieres that have been reclassified in accordance with the provisions of the Federal Food, Drug, de vices that have occh recise in a trequire approval of a premarket approval application (PMA). and Cosmetic recry there the device, subject to the general controls provisions of the Act. The 1 ou may, merciolo, market the Act include requirements for annual registration, listing of general controls provision practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device to such additional controls. Existing major regulations affecting your device can may be subject to satil additions, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean I least of advised that I Dris 1558aarse or our device complies with other requirements of the Act that I DA has made a acterimalations administered by other Federal agencies. You must of any I ederal statutes and regularents, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set (21 CFR Part 807), acceming (21 CFR Part 820); and if applicable, the electronic forul in the quality by over in the end of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Page 2 - Charles H. Creighton

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

A Kalpi Rosenthal

A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Attachment E

Indications For Use Statement

Device Name:Alden HP 55 (methafilcon A) and Alden HP 59G (hioxifilcon A)Sphere and Toric Soft Contact Lenses for Daily Wear
Indications for Use:The Alden HP 55 (methafilcon A) and Alden HP 59G (hioxifilcon A)Sphere and Toric Soft Contact Lenses For Daily Wear, are indicatedfor the correction of visual acuity in aphakic and not aphakic persons withnon-diseased eyes with myopia or hyperopia, and/or possess refractiveastigmatism not exceeding 10 Diopters. They are available for eitherconventional wear or planned replacement modalities.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use x
(Per 21 CFR 801.109)

or

Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________

(Optional Format 1-2-96)

Emanuel W. Branson, Ph.D.

Division of Ophthalmic Devices

510(k) Number K042242

§ 886.5925 Soft (hydrophilic) contact lens.

(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.